NHS Foundation Trust
Formulary Chapter 4: Central nervous system -
Selective serotonin re-uptake inhibitors
Tablets, oral drops
MHRA advice on maximum dose
MHRA safety advice regarding maximum doses and QT prolongation
Capsules, oral liquid
MHRA caution on use in pregnancy
Tablets, oral liquid
Menopausal hot flushes - Antidepressant use for management
NICE CG26: Post-traumatic stress disorder (PTSD)
NICE CG28: Depression in children and young people
NICE CG31: Obsessive-compulsive disorder
NICE CG53: Chronic fatigue syndrome / Myalgic encephalomyelitis
NICE CG90: Depression in adults (update)
NICE CG91: Depression with a chronic physical health problem
Serotonin syndrome: What is it and which medicines cause it
Switching between tricyclic, SSRI and related antidepressants
UKMI QA: Alcohol interaction with antidepressants?
UKMI QA: Antidepressant discontinuation advice
UKMI QA: Antidepressants in renal failure: Which is best?
UKMI QA: Antidepressants: How long do they take to work?
UKMI QA: Breastfeeding mothers and treatment of depression
UKMI QA: Coronary heart disease: What is the anti-depressant of choice for these patients?
UKMI QA: Epileptics - What is the most appropriate antidepressant to use?
UKMI QA: SSRIs with tramadol - Risk of Serotonin Syndrome
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information